The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025.
The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of awareness about human microbiome science is likely to have a negative impact on the growth of the market in the coming years.Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health. The Gut Health Congress was held in Hong Kong Asia in 2018, the conference explore in detail of diet & personalised nutrition, gastrointestinal microbiome and several case studies with regards to clinical studies, diagnostics studies, treatment methods, biomarker developments, molecular therapy and gastrointestinal diseases. Also, the 5th Microbiome R&D and Business Collaboration Congress was held in Taiwan, Asia in March 2019, the conference focused on recent developments in gut microbiome, skin microbiome, infant, women and oral health, therapeutics, microbiome and diet.
Also, many companies are designing and developing many microbiome therapies. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
Japan is anticipated to lead the adoptions of Human microbiome across the Asia Pacific region through the forecast period. Researchers from Japan are using the outcomes of studies on centenarians in the country to try and produce new products that will replicate the beneficial aspects of their microbiota. The goal of the collaboration is to solve few of the major technological hurdles in advancing stem cell research. Moreover, Cykinso (Tokyo) received the US$ 2.3 million (270 million yen) funds from the Regional Health Care Industry Support Fund, develop and sell Mykinso or a test kit for intestinal flora. The company plans to use the funds for business development purposes, which include using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. Thus, the investments and the initiatives taken by the government are likely to propel the growth of the market in the forecast period.
Rest Of Asia Pacific Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By Product
• Probiotics
• Foods
• Prebiotics
• Medical Foods
• Diagnostic Device
• Drugs
• Supplements
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
• Obesity
• Diabetes
• Autoimmune Disorders
• Cancer
• Mental Disorders
• Others
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Application
• Therapeutics
• Diagnostics
By Country
• U.S.
• Canada
• Mexico
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Disease, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Asia Pacific Human microbiome Market – Key takeaways
PART 3. Asia Pacific Human microbiome market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Asia Pacific Human Microbiome Market – By Product
3.2.2 Asia Pacific Human Microbiome Market – By Disease
3.2.3 Asia Pacific Human Microbiome Market – By Application
3.2.4 Asia Pacific Human Microbiome Market North America
3.3 PEST Analysis
3.3.1 Asia Pacific– PEST Analysis
PART 4. Asia Pacific HUMAN MICROBIOME market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Chronic Disease due to change in lifestyle
4.1.2 Growing interest in Human Microbiome Treatment approach
4.2 Key Market Restraints
4.2.1 Stringent regulatory environment
4.2.2 Lack of Awareness About Human Microbiome Science
4.3 Key Market Opportunities
4.3.1 Growing Initiatives To Raise The Awareness in Emerging Nations
4.4 future Trends
4.4.1 The Human Microbiome Drug Development Is Revolutionizing The Medical Industry
4.5 Impact analysis
PART 5. Human microbiome market – Asia Pacific Analysis
5.1 Asia Pacific Human microbiome market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Enterome
Yakult Honsha Co., Ltd.
5.4 expert opinions
PART 6. Asia Pacific Human microbiome market Analysis – By Product
6.1 Overview
6.2 ASIA PACIFIC Human microbiome MARKET, BY product, 2017 & 2025 (%)
6.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
6.4 FOODS Market
6.4.1 Overview
6.4.2 Asia Pacific Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 Medical food Market
6.5.1 Overview
6.5.2 Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 probiotics Market
6.6.1 Overview
6.6.2 Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 prebiotics Market
6.7.1 Overview
6.7.2 Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 drugs Market
6.8.1 Overview
6.8.2 Asia Pacific Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 DIAGNOSTIC DEVICES Market
6.9.1 Overview
6.9.2 Asia Pacific Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.10 SUPPLEMENTS Market
6.10.1 Overview
6.10.2 Asia Pacific Supplements Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. Asia Pacific human microbiome market Analysis – By disease
7.1 Overview
7.2 ASIA PACIFIC HUMAN microbiome MARKET, BY disease, 2017 & 2025 (%)
7.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
7.4 diabetes Market
7.4.1 Overview
7.4.2 Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CANCER Market
7.5.1 Overview
7.5.2 Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 AUTOIMMUNE DISORDERS Market
7.6.1 Overview
7.6.2 Asia Pacific Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 OBESITY Market
7.7.1 Overview
7.7.2 Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 MENTAL DISORDERS Market
7.8.1 Overview
7.8.2 Asia Pacific Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.9 Others Market
7.9.1 Overview
7.9.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. Asia Pacific human microbiome market Analysis – By application
8.1 Overview
8.2 ASIA PACIFIC Human microbiome MARKET, BY application, 2017 & 2025 (%)
8.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
8.4 Diagnostics Market
8.4.1 Overview
8.4.2 Asia Pacific Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 therapeutics Market
8.5.1 Overview
8.5.2 Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9.Asia Pacific Human microbiome Market Revenue and Forecasts to 2025
9.1 Overview
9.2 asia pacific Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.4 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
9.5 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.6 Asia Pacific Human microbiome Market Revenue And Forecasts to 2025, By Country (%)
9.7 China Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 Japan Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 India Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
PART 10. Human Microbiome Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Human Microbiome Market, 2015-2018
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch & Approvals
10.3.3 Expansion
10.3.4 Patent and license
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Acquisitions
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
PART 11. Human microbiome Market–Key company profiles
11.1 ENTEROME
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MICROBIOME THERAPEUTICS, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Rebiotix Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Yakult Honsha Co., Ltd.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Osel Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 Swot Analysis
11.5.6 Key Developments
11.6 Vedanta Biosciences, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Metabiomics Corporate
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Synthetic Biologics, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DuPont
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BiomX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
TABLE 1. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 3. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 4. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 5. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 6. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 7. China Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 8. China Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 9. China Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 10. Japan Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 11. Japan Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 12. Japan Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 13. India Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 14. India Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)
TABLE 15. India Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 16. Recent Product Launches & Approvals in the Human Microbiome Market
TABLE 17. Recent EXPANSIONS in the Human Microbiome Market
TABLE 18. Patent and License Organic Growth Strategies in the Human Microbiome Market
TABLE 19. Recent Acquisitions in the Human Microbiome market
TABLE 20. Recent Partnerships & Collaborations in the Human Microbiome market
TABLE 21. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
TABLE 22. Glossary of Terms, Human microbiome market
LIST OF FIGURES
FIGURE 1. JApan Human microbiome market, Revenue (US$ Mn), 2018 & 2025
FIGURE 2. Asia Pacific human microbiome Market By product, Market Share (%), 2017
FIGURE 3. Asia Pacific Human microbiome Market By disease, Market Share (%), 2017
FIGURE 4. Asia Pacific Human microbiome Market By application, Market Share (%), 2017
FIGURE 5. Human microbiome market Segmentation
FIGURE 6. Asia pacific PEST Analysis
FIGURE 7. human microbiome market impact analysis of drivers & Restraints
FIGURE 8. Asia Pacific Human microbiome market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 9. Asia Pacific Human microbiome market, By Product, 2017 & 2025 (%)
FIGURE 10. Asia Pacific foods Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 11. Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 12. Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. Asia Pacific drugs Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. Asia Pacific DIAGNOSTIC DEVICES Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. Asia Pacific SUPPLEMENTS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. Asia PACIFIC HUMAN microbiome market By disease, 2017 & 2025 (%)
FIGURE 18. Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 20. Asia Pacific Autoimmune Diseases Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 22. Asia Pacific MENTAL DISORDERS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 24. Asia Pacific Human microbiome market By application, 2017 & 2025 (%)
FIGURE 25. Asia Pacific diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 26. Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. Asia Pacific human microbiome Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 28. asia pacific Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Asia Pacific Human microbiome Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 30. China Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 31. Japan Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 32. India Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 33. Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 34. Organic Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 35. Inorganic Growth Strategies in the HUMAN MICROBIOME Market, 2015-2018
The List of Companies - Asia Pacific Human Microbiome Market
- Enterome
- MicroBiome Therapeutics, LLC
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Osel Inc.
- Vedanta Biosciences, Inc.
- Metabiomics Corporate
- Synthetic Biologics, Inc.
- DuPont
- BiomX Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Human Microbiome Market
Feb 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Feb 2019